Compound ID |
Compound Name |
Compound Formula |
CP0447843
|
6-[[(2S)-4-methylmorpholin-2-yl]methoxy]-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]-3H-isoindol-1-one
Show/Hide
|
C24H28N6O3
|
1
|
1 |
EC50 = 6.31 nM
|
|
|
CP0447844
|
2-[6-[4-[(2R)-1-hydroxypropan-2-yl]-1,2,4-triazol-3-yl]pyridin-2-yl]-6-propan-2-yloxy-3H-isoindol-1-one
Show/Hide
|
C21H23N5O3
|
1
|
1 |
EC50 = 6.31 nM
|
|
|
CP0462192
|
2-[6-[4-[(2R)-1-hydroxypropan-2-yl]-1,2,4-triazol-3-yl]pyridin-2-yl]-6-(2-methoxyethoxy)-3H-isoindol-1-one
Show/Hide
|
C21H23N5O4
|
1
|
1 |
EC50 = 12.59 nM
|
|
|
CP0471228
|
6-(2-methoxyethoxy)-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]-3H-isoindol-1-one
Show/Hide
|
C21H23N5O3
|
1
|
1 |
EC50 = 15.85 nM
|
|
|
CP0462188
|
6-propan-2-yloxy-2-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]-3H-isoindol-1-one
Show/Hide
|
C21H23N5O2
|
1
|
1 |
EC50 = 31.62 nM
|
|
|
CP0356981
|
12-oxa-3,4,6,20,25-pentazatetracyclo[19.3.1.02,6.013,18]pentacosa-1(25),2,4,13,15,17,21,23-octaen-19-one
Show/Hide
|
C19H19N5O2
|
1
|
1 |
IC50 = 1000 nM
|
|
|
CP0748625
|
3-(3-(1-(1-ethoxyethyl)-1H-pyrazol-4-yl)phenyl)-5-(4-isopropyl-4H-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C25H27N7O
|
1
|
1 |
IC50 = 4462 nM
|
|
|
CP0487471
|
5-(4-cyclopentyl-1,2,4-triazol-3-yl)-3-[3-(4-cyclopropylimidazol-1-yl)phenyl]-1H-indazole
Show/Hide
|
C26H25N7
|
1
|
1 |
IC50 = 5502 nM
|
|
|
CP0558777
|
3-[3-(4-cyclopropylimidazol-1-yl)phenyl]-5-(4-cyclopropyl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C24H21N7
|
1
|
1 |
IC50 = 7045 nM
|
|
|
CP0228880
|
5-(4-cyclobutyl-1,2,4-triazol-3-yl)-3-[3-(4-cyclopropylimidazol-1-yl)phenyl]-1H-indazole
Show/Hide
|
C25H23N7
|
1
|
1 |
IC50 = 7276 nM
|
|
|
CP0217203
|
GS-4997
Show/Hide
|
C24H24FN7O
|
1
|
1 |
IC50 = 7501 nM
|
|
|
CP0258310
|
3-[3-(1-methylpyrazol-4-yl)phenyl]-5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C22H21N7
|
1
|
1 |
IC50 = 8333 nM
|
|
|
CP0419108
|
3-[3-(4-cyclopropylimidazol-1-yl)-4-methylphenyl]-5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C25H25N7
|
1
|
1 |
IC50 = 8729 nM
|
|
|
CP0562338
|
3-[3-(3-cyclopropyl-1,2,4-triazol-1-yl)phenyl]-5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C23H22N8
|
1
|
1 |
IC50 = 8877 nM
|
|
|
CP0343393
|
3-[3-[1-(methoxymethyl)pyrazol-4-yl]phenyl]-5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C23H23N7O
|
1
|
1 |
IC50 = 9808 nM
|
|
|
CP0564954
|
BDBM50521256
Show/Hide
|
C18H14BrN5O2
|
1
|
1 |
IC50 > 10000 nM
|
|
|
CP0471097
|
3-[3-(4-cyclopropylimidazol-1-yl)-5-methoxyphenyl]-5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C25H25N7O
|
1
|
1 |
IC50 = 11294 nM
|
|
|
CP0176831
|
4-[2-(4-cyclopropylimidazol-1-yl)-4-[5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl]morpholine
Show/Hide
|
C28H30N8O
|
1
|
1 |
IC50 = 11633 nM
|
|
|
CP0271586
|
3-[3-[1-(oxan-4-yl)pyrazol-4-yl]phenyl]-5-(4-propan-2-yl-1,2,4-triazol-3-yl)-1H-indazole
Show/Hide
|
C26H27N7O
|
1
|
1 |
IC50 = 12064 nM
|
|
|
CP0197534
|
US11168095, Example 42
Show/Hide
|
C23H23N7O2
|
1
|
1 |
IC50 <= 1000 nM
|
|
|
CP0204700
|
US11168095, Example 18
Show/Hide
|
C19H19N5O2
|
1
|
1 |
IC50 <= 1000 nM
|
|
|
CP0259270
|
15-morpholin-4-yl-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12(17),13,15,20,22-octaen-18-one
Show/Hide
|
C22H24N6O3
|
1
|
1 |
IC50 <= 1000 nM
|
|
|
CP0384160
|
(9R)-9-methyl-11-oxa-3,4,6,19,24-pentazatetracyclo[18.3.1.02,6.012,17]tetracosa-1(24),2,4,12,14,16,20,22-octaen-18-one
Show/Hide
|
C19H19N5O2
|
1
|
1 |
IC50 <= 1000 nM
|
|
|